focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Defensive stocks buoy FTSE 100 before U.S.-China trade deal

Wed, 15th Jan 2020 09:20

* FTSE 100 up 0.3%, FTSE 250 down 0.2%

* U.S. tariffs on China to remain in place for now

* Tullow Oil drags midcaps lower

* Banks drop on rate cut bets
(Adds company news items, updates to closing prices)

By Shashwat Awasthi and Muvija M

Jan 15 (Reuters) - London's main share index rose slightly
on Wednesday, hours before the sealing of an initial U.S.-China
trade deal, though sentiment was tempered when Washington said
tariffs on Chinese goods would not be rolled back immediately.

The FTSE 100 rose 0.3% on a third day of gains,
supported by a host of so-called defensive stocks including
pharmaceutical giants AstraZeneca and GlaxoSmithKline
, which rose nearly 2%, and consumer goods companies.

Investors tend to turn to these sectors at times of
macroeconomic uncertainty.

The FTSE 250 ended 0.2% lower, with a 16% plunge in
Tullow Oil weighing the most. Tullow said it would take
a $1.5 billion writedown after cutting its long-term oil price
assumptions.

Investors betting on a quick de-escalation of Sino-American
tensions were dealt a blow when U.S. Treasury Secretary Steven
Mnuchin said tariffs on Chinese goods would not be repealed
until the completion of a Phase 2 agreement.

"Strategic competition between the U.S. and China,
especially in tech, is likely to persist despite a limited
'Phase 1' trade deal," BlackRock analysts wrote in their weekly
note.

"The U.S.-China trade conflict – 2019's dominant
geopolitical risk – has paused, yet we expect enduring strategic
rivalry between the two countries."

Banks suffered across the board as weak inflation data
further spurred hopes that the Bank of England will cut interest
rates in its January meeting. Low interest rates squeeze a
lender's margins.

Royal Bank of Scotland, which also had its rating
downgraded by Barclays, led the sub-index down 1%
to a one-month low with a 2.5% share price fall.

Keeping a lid on losses on the midcap bourse, Provident
Financial jumped 7% after its key credit card business
enjoyed a better-than-expected fourth quarter and Hochschild
Mining climbed 3% on better-than-expected 2019
production.

Among smaller stocks, fast fashion retailer QUIZ
tanked nearly 20% on its worst day since June, as it pointed to
poor trading over the key Christmas period.
(Reporting by Shashwat Awasthi and Muvija M in Bengaluru,
Editing by Sherry Jacob-Phillips and Shailesh Kuber)

More News
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more
8 Oct 2023 11:36

Sunday newspaper round-up: Renewi, Metro Bank, New homes

(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times

Read more
6 Oct 2023 08:17

GSK raises £885.6m from Haleon share sale

(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.

Read more
6 Oct 2023 07:57

UPDATE: GSK banks GBP886 million from Haleon share sale

(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC.

Read more
6 Oct 2023 07:46

LONDON BRIEFING: Wetherspoon swings to profit; UK house prices fall

(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.